Therapeutic advantages of long-acting trimetazidine for the treatment of stable angina pectoris in routine clinical practice: findings from ODA trial

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Professor Maria Glezer

I.M. Sechenov First Moscow State Medical University, Moscow (Russian Federation)

16 More presentations in this session

Presentation thumbnail

Fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Accelerated versus standard Streptokinase infusion regimen; a randomized clinical study

Associate Professor A. Bendary (Benha, EG)

Abstract Slides

Presentation thumbnail

Heart rate reduction with ivabradine restores endothelial function and reduces vascular stiffness in patients with chronic stable coronary artery disease

Doctor A. Hohneck (Mannheim, DE)

Abstract Slides

Presentation thumbnail

Comparative efficacy of angiotensin converting enzyme inhibitor and angiotensin receptor blocker for patients with acute myocardial infarction and renal dysfunction

Doctor J. Won (Gwangju, KR)

Presentation thumbnail

Mid-term outcomes of second-generation drug-eluting-stent implantation for left main coronary artery disease compare with first-generation drug-eluting-stent

Doctor G. Yoshioka (Saga, JP)

Presentation thumbnail

The contribution of gender and age on early and late mortality following ST-segment elevation myocardial infarction: results from the Korean acute myocardial infarction national registry

Professor A. Her (Chuncheon, KR)

Access the full session

Session thumbnail

Poster Session 7 - Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation

The Event

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources